Paper Review Records
All Paper Review Records
17 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
New anti-fungal compounds 1PB1 and 45R from Streptomyces chrestomyceticus ADP4 target exo-β-1,3-glucanase and ergosterol biosynthesis in Candida albicans
Jyoti Shukla; Ashok K. DubeyShow moreShow less
1. Department of Biological Sciences and Engineering, Netaji Subhas University of Technology, Dwarka, IndiaShow moreShow less
CSA-13 treatment in a murine model of Pseudomonas pneumonia-induced sepsis and its effects on renal injury, inflammation, and glycocalyx derangement
Ugur Aksu; Cagla Bozkurt-Guzel; Gonca Erkose-Genc; Olgu Enis Tok; Mukaddes Esrefoglu; Ozlem Oyardi; Paul B. SavageShow moreShow less
1. Department of Biology, Science Faculty, Istanbul University, Istanbul, Türkiye; 2. Department of Pharmaceutical Microbiology, Pharmacy Faculty, Istanbul University, Istanbul, Türkiye; 3. Department of Microbiology, Istanbul Medical Faculty, Istanbul University, Istanbul, Türkiye; 4. Department of Histology and Embryology, Medical Faculty, Medipol University, Istanbul, Türkiye; 5. Department of Histology and Embryology, Medical Faculty, Bezmialem Vakif University, Istanbul, Türkiye; 6. Department of Pharmaceutical Microbiology, Pharmacy Faculty, Gazi University, Ankara, Türkiye; 7. Department of Chemistry and Biochemistry, Brigham Young University, Provo, USAShow moreShow less
Two new diastereomeric sterigmatocystin derivatives from the culture broth of Hypomyces sp.
Yongkuk Lee; Dae-Cheol Choi; Dae-Won Ki; Ji-Yul Kim; In-Kyoung Lee; Bong-Sik YunShow moreShow less
1. Division of Biotechnology and Advanced Institute of Environment and Bioscience, College of Environmental and Bioresource Sciences, Jeonbuk National University, Iksan, Korea; 2. Department of Genetic Resources Research, National Marine Biodiversity Institute of Korea, Seocheon, Republic of KoreaShow moreShow less
Taxonomic characterization of Kribbella broussonetiae sp. nov., a novel rare actinomycete isolated from the rhizosphere soil of Broussonetia papyrifera
Ming-Yue Li; Yan Xiao; Jian GaoShow moreShow less
1. School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan, ChinaShow moreShow less
Biological profiling of structurally diverse LEGO-LPPOs reveals differences in antibacterial activity, cytocompatibility, and in vivo tolerability
Jana Sabová; Kateřina Bogdanová; Renata Večeřová; Kristýna Rešová; Viktor Mojr; Dominik Rejman; Peter GálShow moreShow less
1. Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia; 2. Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic; 3. Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Prague, Czech Republic; 4. Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Prague, Czech Republic; 5. Department of Biomedical Research, East-Slovak Institute of Cardiovascular Diseases, Košice, Slovakia; 6. Prague Burn Center, Third Faculty of Medicine, Charles University and University Hospital Královske Vinohrady, Prague, Czech RepublicShow moreShow less
Tsukubacyclinone, a novel angucyclinone compound with anti-inflammatory activity in synovial cell line SW982, produced by Streptomyces sp. K21-0141
Fumito Iizuka; Kentaro Uchida; Yuta Kikuchi; Yuta Awano; Miho Nagayoshi; Saki Ikeuchi; Kugo Takeda; Yoshihisa Ohashi; Gen Inoue; Tomoyasu Hirose; Yuki InahashiShow moreShow less
1. Graduate School of Infection Control Sciences, Kitasato University, Minato-ku, Japan; 2. Department of Orthopaedic Surgery, School of Medicine, Kitasato University, Sagamihara-shi, Japan; 3. Ōmura Satoshi Memorial Institute, Kitasato University, Minato-ku, Japan; 4. Medical School, Okayama University, Okayama-shi, Japan; 5. Department of Medical Engineering and Technology, Graduate School of Medical Sciences, Kitasato University, Sagamihara-shi, JapanShow moreShow less
FAQ
How long does JOURNAL OF ANTIBIOTICS take to review a manuscript?
As of 2026-11-19, CrushSCI has 17 complete review records for JOURNAL OF ANTIBIOTICS. The fastest paper went from submission to acceptance in 53 days (Activation of hamiformamide production in the thermotolerant fungus Hamigera avellanea triggered by co-culture with animal immune cells, received 2026-04-23, accepted 2026-06-15); the slowest took 404 days. The average is 132.2 days and the median is 90 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
